Cassandra and Wendy discuss the evolving landscape of COVID-19 treatments, highlighting the fading promise of hydroxychloroquine and the potential of drugs like remdesivir and dexamethasone in aiding severely ill patients. They delve into the shift in medical recommendations regarding steroid use and the impact on patients' immune responses.
